Clinical Trials
10 trialsNCT07589101 2026-05-15
5T4 Targeting Nanobody Probe for PET Imaging in Solid Tumors
Peking University Cancer Hospital & Institute
Phase NA Not yet recruiting
NCT05775939 2026-02-10
PET/CT Imaging to Evaluate Cardiac Radiation Damage in Patients With Lung or Esophageal Cancer, EUCLID Trial
Thomas Jefferson University
Phase NA Recruiting
NCT05840094 2023-05-03
Multimodalitic Imaging in the N-stage of Lung Cancer
Peking University First Hospital
Phase NA Unknown
NCT05803746 2023-04-07
PD-L2 Targeting Nanobody Radiotracer for PET Imaging of Solid Tumor
Peking University Cancer Hospital & Institute
Phase NA Unknown
NCT00424138 2018-10-11
ACRIN6678
American College of Radiology Imaging Network
Phase NA Terminated
NCT01789892 2018-06-28
Methylprednisolone Before Fludeoxyglucose-Labeled Positron Emission Tomography in Patients With Lung Cancer
Ohio State University Comprehensive Cancer Center
Phase NA Withdrawn
NCT00852644 2018-05-11
Stereotactic Radiosurgery in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer
Boston Medical Center
Phase NA Terminated
NCT00732563 2017-10-18
Fludeoxyglucose F 18 in Detecting Lymph Node Metastasis in Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed by Surgery
Roswell Park Cancer Institute
Phase NA Completed
NCT00004138 2016-07-13
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
Alliance for Clinical Trials in Oncology
Phase NA Completed
NCT01254591 2013-08-26
Positron Emission Tomography/Computed Tomography Scanning Before Surgery in Patients With Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer, Esophageal Cancer, or Head and Neck Cancer
National Cancer Institute (NCI)
Phase NA Unknown